Medication info

Empagliflozin/Metformin Tablet 5/850 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
Dongwha Pharmaceutical Co., Ltd.
Appearance
White, oval-shaped film-coated tablets with a convex shape and a yellowish tint
Packaging
10 tablets/box[10 tablets/PTPX1], 60 tablets/box[10 tablets/PTPX6], 30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 202201662 · Approved 2022.04.22

Summary

Main use
Improves blood glucose control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for use, 4. Adverse reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is required in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated using the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for use, 3. Patients requiring careful administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for use, 2. Patients in whom this medicine must not be used, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Dongwha Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • impaired glycemic control
  • cardiovascular disease
View approved original text

This medication is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes through the combination of empagliflozin and metformin. Particularly, patients with cardiovascular disease whose glycemic control is not adequate should take this medication carefully under the direction of a specialist. This medication effectively helps manage blood sugar levels and is used in the treatment of type 2 diabetes.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for use, 4. Adverse reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is required in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated using the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for use, 3. Patients requiring careful administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for use, 2. Patients in whom this medicine must not be used, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medication helps to control blood sugar levels. However, a rare and serious condition known as lactic acidosis may occur while using this medication, so caution is advised. It should not be used in patients with significantly impaired kidney function or in cases of acute infection or dehydration. Additionally, there is a risk of hypoglycemia when used in conjunction with insulin or other anti-diabetic medications. Before using iodinated contrast agents, this medication should be temporarily discontinued and resumed only after confirming normal kidney function. It is advisable for pregnant or lactating women not to take this medication. This medication may cause side effects such as urinary tract infections or genital infections, increased urination, so any symptoms should be reported to a healthcare professional. Regular monitoring is necessary as it may reduce vitamin B12 levels. Elderly patients may experience decreased kidney function, so dose adjustments and regular kidney function tests are important. During treatment, excessive alcohol should be avoided, and if dietary intake or fluid intake is irregular or insufficient, there is a risk of hypoglycemia or lactic acidosis. In case of overdose, seek medical attention immediately, and this medication can be removed by hemodialysis. This medication is not recommended for children under 18 years.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
Show 148 more
  • abnormal liver function tests
  • hepatitis
  • altered taste
  • itching
  • rash
  • hives
  • erythema vascular edema
  • difficulty urinating
  • interstitial nephritis
  • thirst
  • elevated serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • decreased and deficiency of vitamin B12
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
  • perineal necrosis
  • vulvar milia
  • vulvitis
  • balanitis
  • balanitis
  • vascular stent stenosis
  • vascular stent thrombosis
  • fever
  • vascular edema
  • headache
  • dizziness
  • orthostatic dizziness
  • weakness
  • chest discomfort
  • chest pain
  • increased blood creatinine
  • weight loss
  • vulvar itching
  • genital itching
  • hyperglycemia
  • hyponatremia
  • insomnia
  • anxiety
  • angina
  • myocardial infarction
  • deep vein thrombosis
  • diabetic retinopathy
  • glaucoma
  • retinal detachment
  • blurred vision
  • elevated alanine aminotransferase
  • elevated aspartate aminotransferase
  • ureteral calculi
  • acute kidney injury
  • hematuria
  • urinary stones
  • urinary pain
  • abnormal urination
  • cervical inflammation
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • eye discomfort
  • eye congestion
  • pathological myopia
  • retinal crystals
  • retinal vein occlusion
  • macular retinal detachment
  • eyelid swelling
  • vision impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nasal bleeding
  • asthma
  • age-related dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open eye injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • palpitations
  • tachycardia
  • arteriosclerosis
  • diabetic vascular disease
  • peripheral arterial occlusive disease
  • unstable angina
  • anxiety
  • depression
  • sleep disorders
  • otalgia
  • orthostatic dizziness
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • diarrhea
  • dyspepsia
  • abdominal pain
  • nausea
  • gastritis
  • gastrointestinal disturbance
  • constipation
  • nasopharyngitis
  • herpes zoster
  • dizziness
  • headache
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar itching
  • genital itching
  • dyslipidemia
  • hyperglycemia
  • back pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage ensures the safe preservation of the medication's effectiveness.

Appearance and packaging

Appearance

White, oval-shaped film-coated tablets with a convex shape and a yellowish tint

Package unit

10 tablets/box[10 tablets/PTPX1], 60 tablets/box[10 tablets/PTPX6], 30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.